Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates

Journal of Infectious Diseases

Volumn 190, Issue 11, 2004, Pages 2001-2009

  Tuikue Ndam, Nicaise G ^a   Fievet, Nadine ^b   Bertin, Gwladys ^a   Cottrell, Gilles ^a   Gaye, Alioune ^c   Deloron, Philippe ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^c Ctr de S Roi Baudoin de Guediawaye   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHONDROITIN 4 SULFATE; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VARIANT SURFACE ANTIGEN;

ADULT; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LOW BIRTH WEIGHT; MALARIA; PHENOTYPE; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; ANTIBODIES, PROTOZOAN; CATTLE; CELL ADHESION; CHONDROITIN SULFATES; ERYTHROCYTES; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALARIA, FALCIPARUM; PARITY; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PROTEOCHONDROITIN SULFATES; RECEPTORS, CELL SURFACE; RISK FACTORS;

EID: 9444236863     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425521     Document Type: Article

References (42)

1. Kyes S, Horrocks P, Newbold C. Antigenic variation at the infected red cell surface in malaria. Annu Rev Microbiol 2001; 55:673-707.
2. Flick K, Chen Q. var genes, PfEMP1 and the human host. Mol Biochem Parasitol 2004; 134:3-9.
3. Bray RS, Anderson MJ. Falciparum malaria and pregnancy. Trans R Soc Trop Med Hyg 1979; 73:427-31.
4. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983; 61:1005-16.
5. Shulman CE, Dorman EK, Talisuna AO, et al. A community randomized controlled trial of insecticide-treated bednets for the prevention of malaria and anaemia among primigravid women on the Kenyan coast. Trop Med Int Health 1998; 3:197-204.
6. Steketee RW, Breman JG, Paluku KM, Moore M, Roy J, Ma-Disu M. Malaria infection in pregnant women in Zaire: the effects and the potential for intervention. Ann Trop Med Parasitol 1988; 82:113-20.
7. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996; 272:1502-4.
8. Maubert B, Fievet N, Tami G, Boudin C, Deloron P. Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta. Parasite Immunol 2000; 22:191-9.
9. Brabin B. An assessment of low birthweight risk in primiparae as an indicator of malaria control in pregnancy. Int J Epidemiol 1991; 20:276-83.
10. Menendez C, Ordi J, Ismail MR, et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis 2000; 181:1740-5.
11. Beeson JG, Brown GV, Molyneux ME, Mhango C, Dzinjalamala F, Rogerson SJ. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis 1999; 180:464-72.
12. Achur RN, Valiyaveettil M, Alkhalil A, Ockenhouse CF, Gowda DC. Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta. J Biol Chem 2000; 275:40344-56.
13. Biggs BA, Gooze L, Wycherley K, et al. Antigenic variation in Plasmodium falciparum. Proc Natl Acad Sci USA 1991; 88:9171-4.
14. Newbold CI, Pinches R, Roberts DJ, Marsh K. Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp Parasitol 1992; 75:281-92.
15. Roberts DJ, Craig AG, Berendt AR, et al. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 1992; 357:689-92.
16. Buffet PA, Gamain B, Scheidig C, et al. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. Proc Natl Acad Sci USA 1999; 96:12743-8.
17. Reeder JC, Cowman AF, Davern KM, et al. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by PfEMP1. Proc Natl Acad Sci USA 1999; 96:5198-202.
18. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature 1998; 395:851-2.
19. Maubert B, Fievet N, Tami G, Cot M, Boudin C, Deloron P. Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women. Infect Immun 1999; 67:5367-71.
20. Ricke CH, Staalsoe T, Koram K, et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J Immunol 2000; 165:3309-16.
21. Staalsoe T, Megnekou R, Fievet N, et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis 2001; 184:618-26.
22. O'Neil-Dunne I, Achur RN, Agbor-Enoh ST, et al. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun 2001; 69:7487-92.
23. Sherman IW, Eda S, Winograd E. Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect 2003; 5:897-909.
24. Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun 2003; 71:6620-3.
25. Beeson JG, Mann EJ, Elliott SR, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. J Infect Dis 2004; 189:540-51.
26. Moore J, Nahlen B, Ofulla AVO, et al. A simple perfusion technique of maternal intervillous blood mononuclear cells from human placenta. J Immunol Methods 1997; 209:93-104.
27. Bulmer JN, Rassheed FN, Morrison L, Francis N, Greewood BM. Placental malaria. II. A semiquantitative investigation of the pathological features. Histopathology 1993; 22:219-25.
28. Treutiger CJ, Carlson J, Scholander C, Wahlgren M. The time course of cytoadhesion, immunoglobulin binding, rosette formation, and serum-induced agglutination of Plasmodium falciparum-infected erythrocytes. Am J Trop Med Hyg 1998; 59:202-7.
29. Staalsoe T, Giha IIA, Dodoo D, Theander TG, Hviid L. Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. Cytometry 1999; 35:329-36.
30. Kinyanjui SM, Bull P, Newbold CI, Marsh K. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 2003; 187:667-74.
31. Kassberger F, Birkenmaier A, Khattab A, Kremsner PG, Klinkert MQ. PCR typing of Plasmodium falciparum in matched peripheral, placental and umbilical cord blood. Parasitol Res 2002; 88:1073-9.
32. Schleiermacher D, Le Hesran JY, Ndiaye JL, Perraut R, Gaye A, Mercereau-Puijalon O. Hidden Plasmodium falciparum parasites in human infections: different genotype distribution in the peripheral circulation and in the placenta. Infect Genet Evol 2002; 2:97-105.
33. Ofori MF, Staalsoe T, Bam V, et al. Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection. Infect Immun 2003; 71:1584-6.
34. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312:82-90.
35. Cot M, Brutus L, Pinell V, et al. Malaria prevention during pregnancy in unstable transmission areas: the highlands of Madagascar. Trop Med Int Health 2002; 7:565-72.
36. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004; 363:283-9.
37. Carlson J. Erythrocyte resetting in Plasmodium falciparum malaria-with special reference to the pathogenesis of cerebral malaria. Scand J Infect Dis Suppl 1993; 86:1-79.
38. Klaamas K, Kurtenkov O, Covacci A, Lipping A, Wadstrom T. Immune response to a recombinant fragment of the CagA protein of Helicobacter pylori in blood donors and patients with gastric cancer: relation to ABO(H) blood group phenotype, stage of the disease and tumor morphology. Med Microbiol Immunol (Berl) 1999; 187:227-32.
39. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 2002; 185:1335-7.
40. Blackwell CC, Dundas S, James VS, et al. Blood group and susceptibility to disease caused by Escherichia coli O157. J Infect Dis 2002; 185:393-6.
41. Beeson JG, Rogerson SJ, Cooke BM, et al. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat Med 2000; 6:86-90.
42. Flick K, Scholander C, Chen Q, et al. Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science 2001; 293:2098-100.